MENU
+Compare
GKOS
Stock ticker: NYSE
AS OF
Aug 15, 11:13 AM (EDT)
Price
$90.92
Change
-$0.15 (-0.16%)
Capitalization
5.22B

GKOS Glaukos Corp Forecast, Technical & Fundamental Analysis

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases... Show more

GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GKOS with price predictions
Aug 14, 2025

GKOS in upward trend: price may ascend as a result of having broken its lower Bollinger Band on July 31, 2025

GKOS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 35 cases where GKOS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where GKOS's RSI Indicator exited the oversold zone, of 18 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 56 cases where GKOS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 14, 2025. You may want to consider a long position or call options on GKOS as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GKOS just turned positive on August 13, 2025. Looking at past instances where GKOS's MACD turned positive, the stock continued to rise in of 58 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GKOS advanced for three days, in of 330 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

GKOS moved below its 50-day moving average on July 21, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for GKOS crossed bearishly below the 50-day moving average on July 25, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GKOS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for GKOS entered a downward trend on August 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. GKOS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.826) is normal, around the industry mean (59.733). P/E Ratio (0.000) is within average values for comparable stocks, (38.608). GKOS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.698). GKOS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (11.806) is also within normal values, averaging (92.794).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

GKOS is expected to report earnings to rise 3.38% to -24 cents per share on October 29

Glaukos Corp GKOS Stock Earnings Reports
Q3'25
Est.
$-0.25
Q2'25
Beat
by $0.02
Q1'25
Beat
by $0.13
Q4'24
Missed
by $0.02
Q3'24
Beat
by $0.20
The last earnings report on July 30 showed earnings per share of -23 cents, beating the estimate of -25 cents. With 15.68K shares outstanding, the current market capitalization sits at 5.22B.
A.I. Advisor
published General Information

General Information

an ophthalmic medical device company

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
One Glaukos Way
Phone
+1 949 367-9600
Employees
907
Web
https://www.glaukos.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VEIPX45.93N/A
N/A
Vanguard Equity-Income Inv
IVEIX10.04N/A
N/A
Macquarie Climate Solutions I
DBMAX29.36N/A
N/A
BNY Mellon Sm/Md Cp Gr A
TRBIX25.18N/A
N/A
Nuveen Small Cap Blend Idx Retire
RTDYX16.74-0.02
-0.12%
Russell Inv Multifactor US Equity Y

GKOS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with ISRG. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GKOS
1D Price
Change %
GKOS100%
-0.77%
ISRG - GKOS
51%
Loosely correlated
-1.09%
ITGR - GKOS
48%
Loosely correlated
-2.56%
NTRA - GKOS
48%
Loosely correlated
+0.47%
RDNT - GKOS
48%
Loosely correlated
+0.50%
DXCM - GKOS
46%
Loosely correlated
N/A
More

Groups containing GKOS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GKOS
1D Price
Change %
GKOS100%
-0.77%
Medical/Nursing Services
industry (226 stocks)
53%
Loosely correlated
-0.42%
Health Services
industry (440 stocks)
33%
Poorly correlated
-0.53%